Ligand Pharmaceuticals CFO sells $2.76 million in shares
#Ligand Pharmaceuticals #CFO #stock sale #insider trading #regulatory filing #shares #executive compensation
📌 Key Takeaways
- Ligand Pharmaceuticals CFO sold $2.76 million worth of company shares
- The sale was disclosed in a recent regulatory filing
- Such transactions are common for executives but can signal insider sentiment
- Investors often monitor these sales for potential insights into company outlook
🏷️ Themes
Corporate Finance, Executive Actions
Entity Intersection Graph
No entity connections available yet for this article.